BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30876834)

  • 1. Survival outcomes after whole brain radiotherapy for brain metastases in older adults with newly diagnosed metastatic small cell carcinoma: A national cancer database (NCDB) analysis.
    Renz P; Hasan S; Wegner RE
    J Geriatr Oncol; 2019 Jul; 10(4):560-566. PubMed ID: 30876834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer.
    Robin TP; Jones BL; Amini A; Koshy M; Gaspar LE; Liu AK; Nath SK; Kavanagh BD; Camidge DR; Rusthoven CG
    Lung Cancer; 2018 Jun; 120():88-90. PubMed ID: 29748022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and limitations of salvage gamma knife radiosurgery for brain metastases of small-cell lung cancer after whole-brain radiotherapy.
    Nakazaki K; Higuchi Y; Nagano O; Serizawa T
    Acta Neurochir (Wien); 2013 Jan; 155(1):107-13; discussion 113-4. PubMed ID: 23065044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer.
    Sun H; Xu L; Wang Y; Zhao J; Xu K; Qi J; Yuan Z; Zhao L; Wang P
    Radiat Oncol; 2018 Dec; 13(1):250. PubMed ID: 30563554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer.
    Neuhaus T; Ko Y; Muller RP; Grabenbauer GG; Hedde JP; Schueller H; Kocher M; Stier S; Fietkau R
    Br J Cancer; 2009 Jan; 100(2):291-7. PubMed ID: 19127261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X; Zang QC
    Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
    Nawrocki S; Sugajska A
    BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
    Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
    Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for brain metastases from small cell lung cancer.
    Reveiz L; Rueda JR; Cardona AF
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007464. PubMed ID: 22696370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
    Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
    J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study.
    Ni M; Jiang A; Liu W; Sheng Y; Zeng H; Liu N; Gao Q; Wang Y; Yu J; Yuan S
    Radiat Oncol; 2020 Mar; 15(1):70. PubMed ID: 32213185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
    Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
    Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
    Doherty MK; Korpanty GJ; Tomasini P; Alizadeh M; Jao K; Labbé C; Mascaux CM; Martin P; Kamel-Reid S; Tsao MS; Pintilie M; Liu G; Bradbury PA; Feld R; Leighl NB; Chung C; Shepherd FA
    Radiother Oncol; 2017 May; 123(2):195-202. PubMed ID: 28363487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study.
    Chen LK; Huang H; Liao H; Liu GZ; Zeng YD; Dinglin XX; Xu GC; Wei WD
    Med Oncol; 2012 Sep; 29(3):1687-92. PubMed ID: 21853344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
    Bernhardt D; König L; Aufderstrasse S; Krisam J; Hoerner-Rieber J; Adeberg S; Bozorgmehr F; El Shafie R; Lang K; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Marcrom S; Debus J; Steins M; Rieken S
    Clin Lung Cancer; 2018 Jul; 19(4):340-345. PubMed ID: 29373273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
    Tian J; Luo Y; Xiang J; Tang J
    J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.